Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
NCT ID: NCT01318941
Last Updated: 2016-05-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
30490 participants
OBSERVATIONAL
2011-03-31
2016-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy Study of Ranibizumab on Patients With Age-related Macular Degeneration.
NCT01831947
Observational Study to Evaluate and Compare the Rate and Extent of Inflammation After a Single Intravitreal Injection of Ranibizumab vs. a Single Intravitreal Injection of Aflibercept in Treatment Naive and Treatment Experienced Patients.
NCT01942213
A Clinical Study in Current Medical Practice of the Efficacy and Safety of Ranibizumab 0.5mg in Diabetic Patients Presenting a Visual Impairment Due to Macular Edema
NCT01315275
Observation of Treatment Patterns With Lucentis® in Real-life Conditions in All Approved Indications
NCT04847895
A Randomized Study Comparing Ranibizumab to Sham in Patients With Macular Edema Secondary to CRVO
NCT00567697
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ranibizumab
Ranibizumab
Ranibizumab
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ranibizumab
Ranibizumab
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Willing and able to provide informed written consent personally or by legal proxy
Exclusion Criteria
* Systemic or ocular treatment with any VEGF inhibitor other than ranibizumab in the 90 days prior to enrollment
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Novartis Pharmaceuticals
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Novartis Pharmaceuticals
Role: STUDY_DIRECTOR
Novartis Pharmaceuticals
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Novartis Investigative Site
Porlamar Local 02, Isla Margarita, Venezuela
Novartis Investigative Site
Caracas, , Venezuela
Novartis Investigative Site
Torre Venezuela, Piso 1, , Venezuela
Novartis Investigative Site
Caracas, Piso 6, Ofic. 607, , Venezuela
Novartis Investigative Site
Santa Paula, , Venezuela
Novartis Investigative Site
Buenos Aires, Argentina, Argentina
Novartis Investigative Site
Concepción del Uruguay, Argentina, Argentina
Novartis Investigative Site
Córdoba, Argentina, Argentina
Novartis Investigative Site
Guaymallén, Mendoza, Argentina, Argentina
Novartis Investigative Site
Rosario, Argentina, Argentina
Novartis Investigative Site
San Martin, Buenos Aires, Argentina, Argentina
Novartis Investigative Site
Santa Fe, Argentina, Argentina
Novartis Investigative Site
Lanús, Buenos Aires, Argentina
Novartis Investigative Site
Mar del Plata, Buenos Aires, Argentina
Novartis Investigative Site
Rosario, Santa Fe Province, Argentina
Novartis Investigative Site
Buenos Aires, , Argentina
Novartis Investigative Site
Buenos Aires, , Argentina
Novartis Investigative Site
Buenos Aires, , Argentina
Novartis Investigative Site
Caballito, , Argentina
Novartis Investigative Site
Ciudad de Buenos Aires,, , Argentina
Novartis Investigative Site
La Plata, , Argentina
Novartis Investigative Site
Santa Fe, , Argentina
Novartis Investigative Site
Chatswood, New South Wales, Australia
Novartis Investigative Site
Forster, New South Wales, Australia
Novartis Investigative Site
Kogarah, New South Wales, Australia
Novartis Investigative Site
Liverpool, New South Wales, Australia
Novartis Investigative Site
North Ryde, New South Wales, Australia
Novartis Investigative Site
Parramatta, New South Wales, Australia
Novartis Investigative Site
Strathfield, New South Wales, Australia
Novartis Investigative Site
Sydney, New South Wales, Australia
Novartis Investigative Site
Sydney, New South Wales, Australia
Novartis Investigative Site
Westmead, New South Wales, Australia
Novartis Investigative Site
Brisbane, Queensland, Australia
Novartis Investigative Site
South Brisbane, Queensland, Australia
Novartis Investigative Site
Southport, Queensland, Australia
Novartis Investigative Site
Adelaide, South Australia, Australia
Novartis Investigative Site
North Adelaide, South Australia, Australia
Novartis Investigative Site
Hobart, Tasmania, Australia
Novartis Investigative Site
South Launceston, Tasmania, Australia
Novartis Investigative Site
East Melbourne, Victoria, Australia
Novartis Investigative Site
Geelong, Victoria, Australia
Novartis Investigative Site
Glen Waverley, Victoria, Australia
Novartis Investigative Site
Oakleigh, Victoria, Australia
Novartis Investigative Site
Linz, , Austria
Novartis Investigative Site
Vienna, , Austria
Novartis Investigative Site
Aalst, Belgium, Belgium
Novartis Investigative Site
Aarschot, Belgium, Belgium
Novartis Investigative Site
Bonheiden, , Belgium
Novartis Investigative Site
Brussels, , Belgium
Novartis Investigative Site
Dinant, , Belgium
Novartis Investigative Site
Edegem, , Belgium
Novartis Investigative Site
Ghent, , Belgium
Novartis Investigative Site
Hasselt, , Belgium
Novartis Investigative Site
Leuven, , Belgium
Novartis Investigative Site
Mouscron, , Belgium
Novartis Investigative Site
Namur, , Belgium
Novartis Investigative Site
Nivelles, , Belgium
Novartis Investigative Site
Reet, , Belgium
Novartis Investigative Site
Yvoir, , Belgium
Novartis Investigative Site
Zottegem, , Belgium
Novartis Investigative Site
Goiânia, Goiás, Brazil
Novartis Investigative Site
Belo Horizonte, Minas Gerais, Brazil
Novartis Investigative Site
Rio de Janeiro, Rio de Janeiro, Brazil
Novartis Investigative Site
Porto Alegre, Rio Grande do Sul, Brazil
Novartis Investigative Site
Campinas, São Paulo, Brazil
Novartis Investigative Site
São Paulo, São Paulo, Brazil
Novartis Investigative Site
Calgary, Alberta, Canada
Novartis Investigative Site
Victoria, British Columbia, Canada
Novartis Investigative Site
Miramichi, New Brunswick, Canada
Novartis Investigative Site
Halifax, Nova Scotia, Canada
Novartis Investigative Site
Brampton, Ontario, Canada
Novartis Investigative Site
Downsview, Ontario, Canada
Novartis Investigative Site
East Brockville, Ontario, Canada
Novartis Investigative Site
London, Ontario, Canada
Novartis Investigative Site
Ottawa, Ontario, Canada
Novartis Investigative Site
Ottawa, Ontario, Canada
Novartis Investigative Site
Scarborough Village, Ontario, Canada
Novartis Investigative Site
Toronto, Ontario, Canada
Novartis Investigative Site
Vaughan, Ontario, Canada
Novartis Investigative Site
Boisbriand, Quebec, Canada
Novartis Investigative Site
Barrie, , Canada
Novartis Investigative Site
Drummondville, , Canada
Novartis Investigative Site
Hamilton, , Canada
Novartis Investigative Site
Ontario, , Canada
Novartis Investigative Site
Calama, , Chile
Novartis Investigative Site
Beijing, Beijing Municipality, China
Novartis Investigative Site
Beijing, Beijing Municipality, China
Novartis Investigative Site
Beijing, Beijing Municipality, China
Novartis Investigative Site
Guangzhou, Guangdong, China
Novartis Investigative Site
Guiyang, Guizhou, China
Novartis Investigative Site
Wuhan, Hubei, China
Novartis Investigative Site
Jinan, Shandong, China
Novartis Investigative Site
Tianjin, Tianjin Municipality, China
Novartis Investigative Site
Kunming, Yunnan, China
Novartis Investigative Site
Beijing, , China
Novartis Investigative Site
Beijing, , China
Novartis Investigative Site
Beijing, , China
Novartis Investigative Site
Changchun, , China
Novartis Investigative Site
Chongqing, , China
Novartis Investigative Site
Fujian, , China
Novartis Investigative Site
Shanghai, , China
Novartis Investigative Site
Shanghai, , China
Novartis Investigative Site
Shanghai, , China
Novartis Investigative Site
Ürümqi, , China
Novartis Investigative Site
Barranquilla, Atlántico, Colombia
Novartis Investigative Site
Armenia, Quindío Department, Colombia
Novartis Investigative Site
Bogotá, , Colombia
Novartis Investigative Site
Cali, , Colombia
Novartis Investigative Site
Yopal, , Colombia
Novartis Investigative Site
San José, Costa Rica, Costa Rica
Novartis Investigative Site
Brno - Bohunice, Czech Republic, Czechia
Novartis Investigative Site
Hradec Králové, , Czechia
Novartis Investigative Site
Olomouc, , Czechia
Novartis Investigative Site
Ostrava-Poruba, , Czechia
Novartis Investigative Site
Pilsen, , Czechia
Novartis Investigative Site
Prague, , Czechia
Novartis Investigative Site
Prague, , Czechia
Novartis Investigative Site
Prague, , Czechia
Novartis Investigative Site
Ustri Nad Labem, , Czechia
Novartis Investigative Site
Santo Domingo, Republica Dominicana, Dominican Republic
Novartis Investigative Site
Ciudadela Kennedy, Guayaquil, Ecuador
Novartis Investigative Site
Cairo, Cairo Governorate, Egypt
Novartis Investigative Site
Giza, , Egypt
Novartis Investigative Site
Poitiers, France, France
Novartis Investigative Site
Bordeaux, , France
Novartis Investigative Site
Créteil, , France
Novartis Investigative Site
Dijon, , France
Novartis Investigative Site
Lyon, , France
Novartis Investigative Site
Melun, , France
Novartis Investigative Site
Montargis, , France
Novartis Investigative Site
Montauban, , France
Novartis Investigative Site
Nantes, , France
Novartis Investigative Site
Nice, , France
Novartis Investigative Site
Paris, , France
Novartis Investigative Site
Paris, , France
Novartis Investigative Site
Paris, , France
Novartis Investigative Site
Paris, , France
Novartis Investigative Site
Reims, , France
Novartis Investigative Site
Toulouse, , France
Novartis Investigative Site
Vannes, , France
Novartis Investigative Site
Augsburg, , Germany
Novartis Investigative Site
Berlin, , Germany
Novartis Investigative Site
Berlin, , Germany
Novartis Investigative Site
Bonn, , Germany
Novartis Investigative Site
Cologne, , Germany
Novartis Investigative Site
Dannenberg, , Germany
Novartis Investigative Site
Hamburg, , Germany
Novartis Investigative Site
Ingolstadt, , Germany
Novartis Investigative Site
Lüdenscheid, , Germany
Novartis Investigative Site
Münster, , Germany
Novartis Investigative Site
Münster, , Germany
Novartis Investigative Site
Neu-Ulm, , Germany
Novartis Investigative Site
Osnabrück, , Germany
Novartis Investigative Site
Regensburg, , Germany
Novartis Investigative Site
Rothenburg, , Germany
Novartis Investigative Site
Schriesheim, , Germany
Novartis Investigative Site
Tönisvorst, , Germany
Novartis Investigative Site
Tübingen, , Germany
Novartis Investigative Site
Alexandroupoli, Greece, Greece
Novartis Investigative Site
Athens, Greece, Greece
Novartis Investigative Site
Athens, Greece, Greece
Novartis Investigative Site
Athens, GR, Greece
Novartis Investigative Site
Heraklion - Crete, GR, Greece
Novartis Investigative Site
Larissa, GR, Greece
Novartis Investigative Site
Patra - RIO, GR, Greece
Novartis Investigative Site
Rethymno, GR, Greece
Novartis Investigative Site
Thessaloniki, GR, Greece
Novartis Investigative Site
Athens, , Greece
Novartis Investigative Site
Lamia, Phthiotis, , Greece
Novartis Investigative Site
Guatemala City, Departamento de Guatemala, Guatemala
Novartis Investigative Site
Kowloon, Hong Kong, Hong Kong
Novartis Investigative Site
Budapest, , Hungary
Novartis Investigative Site
Budapest, , Hungary
Novartis Investigative Site
Debrecen, , Hungary
Novartis Investigative Site
Pécs, , Hungary
Novartis Investigative Site
Szeged, , Hungary
Novartis Investigative Site
Patia, Bhudaneswar, India
Novartis Investigative Site
Chennai, Tamil Nadu, India
Novartis Investigative Site
Coimbatore, Tamil Nadu, India
Novartis Investigative Site
Hyderabad, Telangana, India
Novartis Investigative Site
Ahmedabad, , India
Novartis Investigative Site
New Delhi, , India
Novartis Investigative Site
Dublin, , Ireland
Novartis Investigative Site
Dublin, , Ireland
Novartis Investigative Site
Waterford, , Ireland
Novartis Investigative Site
Haifa, , Israel
Novartis Investigative Site
Petah Tikva, , Israel
Novartis Investigative Site
Tel Aviv, , Israel
Novartis Investigative Site
Acquaviva delle Fonti, BA, Italy
Novartis Investigative Site
Cagliari, CA, Italy
Novartis Investigative Site
Genova, GE, Italy
Novartis Investigative Site
Alessandria, , Italy
Novartis Investigative Site
Belluno, , Italy
Novartis Investigative Site
Brescia, , Italy
Novartis Investigative Site
Pisa, , Italy
Novartis Investigative Site
Reggio Calabria, , Italy
Novartis Investigative Site
Roma, , Italy
Novartis Investigative Site
Roma, , Italy
Novartis Investigative Site
Nagakute, Aichi-ken, Japan
Novartis Investigative Site
Nagoya, Aichi-ken, Japan
Novartis Investigative Site
Nagoya, Aichi-ken, Japan
Novartis Investigative Site
Nagoya, Aichi-ken, Japan
Novartis Investigative Site
Toyoake, Aichi-ken, Japan
Novartis Investigative Site
Aomori, Aomori, Japan
Novartis Investigative Site
Sakura, Chiba, Japan
Novartis Investigative Site
Matsuyama, Ehime, Japan
Novartis Investigative Site
Yoshida-gun, Fukui, Japan
Novartis Investigative Site
Fukuoka, Fukuoka, Japan
Novartis Investigative Site
Fukuoka, Fukuoka, Japan
Novartis Investigative Site
Kitakyushu, Fukuoka, Japan
Novartis Investigative Site
Fukushima, Fukushima, Japan
Novartis Investigative Site
Maebashi, Gunma, Japan
Novartis Investigative Site
Hiroshima, Hiroshima, Japan
Novartis Investigative Site
Sapporo, Hokkaido, Japan
Novartis Investigative Site
Sapporo, Hokkido, Japan
Novartis Investigative Site
Amagasaki, Hyōgo, Japan
Novartis Investigative Site
Kobe, Hyōgo, Japan
Novartis Investigative Site
Nishinomiya, Hyōgo, Japan
Novartis Investigative Site
Inashiki-gun, Ibaraki, Japan
Novartis Investigative Site
Tsukuba, Ibaraki, Japan
Novartis Investigative Site
Kanazawa, Ishikawa-ken, Japan
Novartis Investigative Site
Kita-gun, Kagawa-ken, Japan
Novartis Investigative Site
Ashigarakami-gun, Kanagawa, Japan
Novartis Investigative Site
Yokohama, Kanagawa, Japan
Novartis Investigative Site
Yokosuka, Kanagawa, Japan
Novartis Investigative Site
Yokohama, Kangawa, Japan
Novartis Investigative Site
Kyoto, Kyoto, Japan
Novartis Investigative Site
Tsu, Mie-ken, Japan
Novartis Investigative Site
Sendai, Miyagi, Japan
Novartis Investigative Site
Miyakonojō, Miyazaki, Japan
Novartis Investigative Site
Miyazaki, Miyazaki, Japan
Novartis Investigative Site
Suwa, Nagano, Japan
Novartis Investigative Site
Nagasaki, Nagasaki, Japan
Novartis Investigative Site
Kashihara, Nara, Japan
Novartis Investigative Site
Hirakata, Osaka, Japan
Novartis Investigative Site
Osaka, Osaka, Japan
Novartis Investigative Site
Sayama, Osaka, Japan
Novartis Investigative Site
Saitama, Saitama, Japan
Novartis Investigative Site
Saitama, Saitama, Japan
Novartis Investigative Site
Hamamatsu, Shizuoka, Japan
Novartis Investigative Site
Izunokuni, Shizuoka, Japan
Novartis Investigative Site
Shizuoka, Shizuoka, Japan
Novartis Investigative Site
Shimotsuka-gun, Tochigi, Japan
Novartis Investigative Site
Tokushima, Tokushima, Japan
Novartis Investigative Site
Bunkyo-ku, Tokyo, Japan
Novartis Investigative Site
Chiyoda-ku, Tokyo, Japan
Novartis Investigative Site
Mitaka, Tokyo, Japan
Novartis Investigative Site
Nerima-ku, Tokyo, Japan
Novartis Investigative Site
Shinjuku-ku, Tokyo, Japan
Novartis Investigative Site
Shinjuku-ku, Tokyo, Japan
Novartis Investigative Site
Urayasu, Tokyo, Japan
Novartis Investigative Site
Imizu-shi, Toyama, Japan
Novartis Investigative Site
Toyama, Toyama, Japan
Novartis Investigative Site
Yamagata, Yamagata, Japan
Novartis Investigative Site
Chūō, Yamanashi, Japan
Novartis Investigative Site
Akita, , Japan
Novartis Investigative Site
Chiyoda-ku, , Japan
Novartis Investigative Site
Ehime, , Japan
Novartis Investigative Site
Gifu, , Japan
Novartis Investigative Site
Hamamatsu, , Japan
Novartis Investigative Site
Hokkaido, , Japan
Novartis Investigative Site
Hokkaido, , Japan
Novartis Investigative Site
Hyōgo, , Japan
Novartis Investigative Site
Ishikawa, , Japan
Novartis Investigative Site
Kagoshima, , Japan
Novartis Investigative Site
Kagoshima, , Japan
Novartis Investigative Site
Kakogawa-shi, , Japan
Novartis Investigative Site
Kanagawa, , Japan
Novartis Investigative Site
Kawasaki-shi, , Japan
Novartis Investigative Site
Kitami-shi, , Japan
Novartis Investigative Site
Koriyama-shi, , Japan
Novartis Investigative Site
Kouchi, , Japan
Novartis Investigative Site
Kyoto, , Japan
Novartis Investigative Site
Miyagi, , Japan
Novartis Investigative Site
Nagano, , Japan
Novartis Investigative Site
Nagasaki, , Japan
Novartis Investigative Site
Nantan-shi, , Japan
Novartis Investigative Site
Osaka, , Japan
Novartis Investigative Site
Ōtsu, , Japan
Novartis Investigative Site
Saitama-ken, , Japan
Novartis Investigative Site
Sanjo-shi, , Japan
Novartis Investigative Site
Shizuoka, , Japan
Novartis Investigative Site
Shunan-shi, , Japan
Novartis Investigative Site
Tochigi, , Japan
Novartis Investigative Site
Tokyo, , Japan
Novartis Investigative Site
Tokyo, , Japan
Novartis Investigative Site
Toyohashi, , Japan
Novartis Investigative Site
Wakayama, , Japan
Novartis Investigative Site
Yamagata, , Japan
Novartis Investigative Site
Batu Caves, Selangor, Malaysia
Novartis Investigative Site
Kuala Lumpur, , Malaysia
Novartis Investigative Site
Kuala Lumpur, , Malaysia
Novartis Investigative Site
Kuala Lumpur, , Malaysia
Novartis Investigative Site
Col. Lomas de Chapultepec, CP, Mexico
Novartis Investigative Site
Mexico City, Mexico City, Mexico
Novartis Investigative Site
Mexico City, Mexico City, Mexico
Novartis Investigative Site
Monterray, Nuevo León, Mexico
Novartis Investigative Site
Monterrey, Nuevo León, Mexico
Novartis Investigative Site
Mérida, Yucatán, Mexico
Novartis Investigative Site
Almere Stad, , Netherlands
Novartis Investigative Site
Amsterdam, , Netherlands
Novartis Investigative Site
Tilburg, , Netherlands
Novartis Investigative Site
Panama City, Provincia de Panamá, Panama
Novartis Investigative Site
Panama City, Provincia de Panamá, Panama
Novartis Investigative Site
Lima, Lima Province, Peru
Novartis Investigative Site
San Borja, Lima region, Peru
Novartis Investigative Site
San Isidro, Lima region, Peru
Novartis Investigative Site
Bydgoszcz, , Poland
Novartis Investigative Site
Chojnice, , Poland
Novartis Investigative Site
Chorzów, , Poland
Novartis Investigative Site
Gdansk, , Poland
Novartis Investigative Site
Gda¿sk, , Poland
Novartis Investigative Site
Kalisz, , Poland
Novartis Investigative Site
Kielce, , Poland
Novartis Investigative Site
Krakow, , Poland
Novartis Investigative Site
Lodz, , Poland
Novartis Investigative Site
Olsztyn, , Poland
Novartis Investigative Site
Poznan, , Poland
Novartis Investigative Site
Warsaw, , Poland
Novartis Investigative Site
Warsaw, , Poland
Novartis Investigative Site
Wałbrzych, , Poland
Novartis Investigative Site
Wołomin, , Poland
Novartis Investigative Site
Coimbra, Portugal, Portugal
Novartis Investigative Site
Coimbra, Portugal, Portugal
Novartis Investigative Site
Aveiro, , Portugal
Novartis Investigative Site
Leiria, , Portugal
Novartis Investigative Site
Lisbon, , Portugal
Novartis Investigative Site
Matosinhos Municipality, , Portugal
Novartis Investigative Site
Santa Maria da Feira, , Portugal
Novartis Investigative Site
Cheboksary, , Russia
Novartis Investigative Site
Chelyabinsk, , Russia
Novartis Investigative Site
Chita, , Russia
Novartis Investigative Site
Irkutsk, , Russia
Novartis Investigative Site
Kazan', , Russia
Novartis Investigative Site
Khabarovsk, , Russia
Novartis Investigative Site
Krasnodar, , Russia
Novartis Investigative Site
Moscow, , Russia
Novartis Investigative Site
Moscow, , Russia
Novartis Investigative Site
Moscow, , Russia
Novartis Investigative Site
Novosibirsk, , Russia
Novartis Investigative Site
Penza, , Russia
Novartis Investigative Site
Saint Petersburg, , Russia
Novartis Investigative Site
Samara, , Russia
Novartis Investigative Site
Saratov, , Russia
Novartis Investigative Site
Surgut, , Russia
Novartis Investigative Site
Tambov, , Russia
Novartis Investigative Site
Tyumen, , Russia
Novartis Investigative Site
Ufa, , Russia
Novartis Investigative Site
Yakutsk, , Russia
Novartis Investigative Site
Riyadh, , Saudi Arabia
Novartis Investigative Site
Riyadh, , Saudi Arabia
Novartis Investigative Site
Riyadh, , Saudi Arabia
Novartis Investigative Site
Singapore, Singapore, Singapore
Novartis Investigative Site
Singapore, , Singapore
Novartis Investigative Site
Singapore, , Singapore
Novartis Investigative Site
Banksa Bystrica, Slovak Republic, Slovakia
Novartis Investigative Site
Trebišov, Slovak Republic, Slovakia
Novartis Investigative Site
Bratislava, Slovakia, Slovakia
Novartis Investigative Site
Nové Zámky, Slovakia, Slovakia
Novartis Investigative Site
Zvolen, Slovakia, Slovakia
Novartis Investigative Site
Žilina, Slovakia, Slovakia
Novartis Investigative Site
Bratislava, , Slovakia
Novartis Investigative Site
Bratislava, , Slovakia
Novartis Investigative Site
Ljubljana, , Slovakia
Novartis Investigative Site
Poprad, , Slovakia
Novartis Investigative Site
Ružomberok, , Slovakia
Novartis Investigative Site
Trenčín, , Slovakia
Novartis Investigative Site
Novo Mesto, Slovenia, Slovenia
Novartis Investigative Site
Celje, , Slovenia
Novartis Investigative Site
Ljubljana, , Slovenia
Novartis Investigative Site
Maribor, , Slovenia
Novartis Investigative Site
Seongnam-si, Gyeonggi-do, South Korea
Novartis Investigative Site
Suwon, Gyeonggi-do, South Korea
Novartis Investigative Site
Seoul, Korea, South Korea
Novartis Investigative Site
Seoul, Korea, South Korea
Novartis Investigative Site
Busan, , South Korea
Novartis Investigative Site
Daegu, , South Korea
Novartis Investigative Site
Pusan, , South Korea
Novartis Investigative Site
Seoul, , South Korea
Novartis Investigative Site
Seoul, , South Korea
Novartis Investigative Site
Seoul, , South Korea
Novartis Investigative Site
Seoul, , South Korea
Novartis Investigative Site
Seoul, , South Korea
Novartis Investigative Site
Taegu, , South Korea
Novartis Investigative Site
Málaga, Andalusia, Spain
Novartis Investigative Site
León, Castille and León, Spain
Novartis Investigative Site
Salamanca, Castille and León, Spain
Novartis Investigative Site
Valladolid, Castille and León, Spain
Novartis Investigative Site
Barcelona, Catalonia, Spain
Novartis Investigative Site
Sant Cugat del Vallès, Catalonia, Spain
Novartis Investigative Site
Tarragona, Catalonia, Spain
Novartis Investigative Site
Lugo, Galicia, Spain
Novartis Investigative Site
Logroño, Hospital La Rioja Provincia, Spain
Novartis Investigative Site
Murcia, Murcia, Spain
Novartis Investigative Site
Valencia, Valencia, Spain
Novartis Investigative Site
Valencia, Valencia, Spain
Novartis Investigative Site
Zaragoza, Zaragoza, Spain
Novartis Investigative Site
Barcelona, , Spain
Novartis Investigative Site
Burgos, , Spain
Novartis Investigative Site
Granollers, , Spain
Novartis Investigative Site
Madrid, , Spain
Novartis Investigative Site
Madrid, , Spain
Novartis Investigative Site
Madrid, , Spain
Novartis Investigative Site
Madrid, , Spain
Novartis Investigative Site
Madrid, , Spain
Novartis Investigative Site
Zaragoza, , Spain
Novartis Investigative Site
Ankara, Turkey, Turkey (Türkiye)
Novartis Investigative Site
Altindag / Ankara, , Turkey (Türkiye)
Novartis Investigative Site
Ankara, , Turkey (Türkiye)
Novartis Investigative Site
Mecidiyekoy/Istanbul, , Turkey (Türkiye)
Novartis Investigative Site
Dnipropetrovsk, , Ukraine
Novartis Investigative Site
Kyiv, , Ukraine
Novartis Investigative Site
Luhansk, , Ukraine
Novartis Investigative Site
Odesa, , Ukraine
Novartis Investigative Site
Truro, Cornwall, United Kingdom
Novartis Investigative Site
Durham, County Durham, United Kingdom
Novartis Investigative Site
Torquay, Devon,, United Kingdom
Novartis Investigative Site
Bolton, England, United Kingdom
Novartis Investigative Site
Solihull, England, United Kingdom
Novartis Investigative Site
Southampton, England, United Kingdom
Novartis Investigative Site
Wakefield, England, United Kingdom
Novartis Investigative Site
Belfast, Essex, United Kingdom
Novartis Investigative Site
Romford, Essex, United Kingdom
Novartis Investigative Site
Cheltenham, Gloucestershire, United Kingdom
Novartis Investigative Site
Blackburn, Lancashire, United Kingdom
Novartis Investigative Site
Hull, Lancashire, United Kingdom
Novartis Investigative Site
Leicester, Lancashire, United Kingdom
Novartis Investigative Site
Coventry, London, United Kingdom
Novartis Investigative Site
Derby, London, United Kingdom
Novartis Investigative Site
Leytonstone, London, United Kingdom
Novartis Investigative Site
Oxford, Oxfordshire, United Kingdom
Novartis Investigative Site
Sheffield, South Yorkshire, United Kingdom
Novartis Investigative Site
Stoke-on-Trent, Staffordshire, United Kingdom
Novartis Investigative Site
Frimley, Surrey, United Kingdom
Novartis Investigative Site
Guildford, Surrey, United Kingdom
Novartis Investigative Site
Worcester, UK, United Kingdom
Novartis Investigative Site
London, United Kingdom, United Kingdom
Novartis Investigative Site
Bradford, West Yorkshire, United Kingdom
Novartis Investigative Site
Bedford, , United Kingdom
Novartis Investigative Site
Birmingham, , United Kingdom
Novartis Investigative Site
Bristol, , United Kingdom
Novartis Investigative Site
Cardiff, , United Kingdom
Novartis Investigative Site
Cheshire, , United Kingdom
Novartis Investigative Site
Colchester, , United Kingdom
Novartis Investigative Site
Inverness, , United Kingdom
Novartis Investigative Site
Kent, , United Kingdom
Novartis Investigative Site
Leeds, , United Kingdom
Novartis Investigative Site
Liverpool, , United Kingdom
Novartis Investigative Site
London, , United Kingdom
Novartis Investigative Site
London, , United Kingdom
Novartis Investigative Site
London, , United Kingdom
Novartis Investigative Site
Maidstone, , United Kingdom
Novartis Investigative Site
Manchester, , United Kingdom
Novartis Investigative Site
Merseyside, , United Kingdom
Novartis Investigative Site
Merseyside, , United Kingdom
Novartis Investigative Site
Middlesbrough, , United Kingdom
Novartis Investigative Site
Newport, , United Kingdom
Novartis Investigative Site
Portsmouth, , United Kingdom
Novartis Investigative Site
Southend, , United Kingdom
Novartis Investigative Site
Sunderland, , United Kingdom
Novartis Investigative Site
Uxbridge, , United Kingdom
Novartis Investigative Site
Wolverhampton, , United Kingdom
Novartis Investigative Site
York, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Holz FG, Minnella AM, Tuli R, Yoganathan P, Parikh S, Hamilton R; LUMINOUS study group. Ranibizumab treatment patterns in prior ranibizumab-treated neovascular age-related macular degeneration patients: Real-world outcomes from the LUMINOUS study. PLoS One. 2020 Dec 30;15(12):e0244183. doi: 10.1371/journal.pone.0244183. eCollection 2020.
Leys AM, Ramboer E, Favreau M, Denhaerynck K, MacDonald K, Abraham I, Brie H. Long-Term Ranibizumab Treatment in Neovascular Age-Related Macular Degeneration: A Belgian Subanalysis from the Global Real-World LUMINOUSTM Study. Clin Ophthalmol. 2020 Jun 2;14:1473-1481. doi: 10.2147/OPTH.S242547. eCollection 2020.
Pearce I, Clemens A, Brent MH, Lu L, Gallego-Pinazo R, Minnella AM, Creuzot-Garcher C, Spital G, Sakamoto T, Dunger-Baldauf C, McAllister IL; all the LUMINOUS study investigators. Real-world outcomes with ranibizumab in branch retinal vein occlusion: The prospective, global, LUMINOUS study. PLoS One. 2020 Jun 18;15(6):e0234739. doi: 10.1371/journal.pone.0234739. eCollection 2020.
Mitchell P, Sheidow TG, Farah ME, Mahmood S, Minnella AM, Eter N, Eldem B, Al-Dhibi H, Macfadden W, Parikh S, Dunger-Baldauf C, Mahgoub MM, Schmidt-Erfurth U; LUMINOUS study investigators. Effectiveness and safety of ranibizumab 0.5 mg in treatment-naive patients with diabetic macular edema: Results from the real-world global LUMINOUS study. PLoS One. 2020 Jun 3;15(6):e0233595. doi: 10.1371/journal.pone.0233595. eCollection 2020.
Schmidt-Erfurth U, Chong V, Loewenstein A, Larsen M, Souied E, Schlingemann R, Eldem B, Mones J, Richard G, Bandello F; European Society of Retina Specialists. Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA). Br J Ophthalmol. 2014 Sep;98(9):1144-67. doi: 10.1136/bjophthalmol-2014-305702.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CRFB002A2406
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.